3/4
07:17 pm
vrdn
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Tousignant Jennifer
Medium
Report
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Tousignant Jennifer
3/4
07:15 pm
vrdn
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Harmon Seth
Medium
Report
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Harmon Seth
3/4
07:14 pm
vrdn
Form 4/A Viridian Therapeutics, For: Mar 03 Filed by: Harmon Seth
Medium
Report
Form 4/A Viridian Therapeutics, For: Mar 03 Filed by: Harmon Seth
3/4
07:11 pm
vrdn
Form 4/A Viridian Therapeutics, For: Mar 03 Filed by: Tousignant Jennifer
Medium
Report
Form 4/A Viridian Therapeutics, For: Mar 03 Filed by: Tousignant Jennifer
3/4
06:59 pm
vrdn
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Beetham Thomas W.
Medium
Report
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Beetham Thomas W.
3/4
06:56 pm
vrdn
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Mahoney Stephen F.
Medium
Report
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Mahoney Stephen F.
3/4
06:51 pm
vrdn
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Tripuraneni Radhika
Medium
Report
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Tripuraneni Radhika
3/4
04:30 pm
vrdn
Form 144 Viridian Therapeutics, Filed by: Beetham Thomas W.
Medium
Report
Form 144 Viridian Therapeutics, Filed by: Beetham Thomas W.
3/4
04:25 pm
vrdn
Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer
Medium
Report
Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer
3/4
04:20 pm
vrdn
Form 144 Viridian Therapeutics, Filed by: Harmon Seth
Medium
Report
Form 144 Viridian Therapeutics, Filed by: Harmon Seth
3/4
04:11 pm
vrdn
Form 144 Viridian Therapeutics, Filed by: Mahoney Stephen F.
Medium
Report
Form 144 Viridian Therapeutics, Filed by: Mahoney Stephen F.
2/26
04:31 pm
vrdn
Form S-8 Viridian Therapeutics,
Low
Report
Form S-8 Viridian Therapeutics,
2/26
07:31 am
vrdn
Form 10-K Viridian Therapeutics, For: Dec 31
Medium
Report
Form 10-K Viridian Therapeutics, For: Dec 31
2/26
07:13 am
vrdn
Form 8-K Viridian Therapeutics, For: Feb 26
Medium
Report
Form 8-K Viridian Therapeutics, For: Feb 26
2/17
12:53 pm
vrdn
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Kynam Capital Management, LP
Low
Report
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Kynam Capital Management, LP
2/13
08:53 am
vrdn
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Deep Track Capital, LP
1/2
05:26 pm
vrdn
Form 4 Viridian Therapeutics, For: Dec 31 Filed by: Tousignant Jennifer
Low
Report
Form 4 Viridian Therapeutics, For: Dec 31 Filed by: Tousignant Jennifer
12/31
12:25 pm
vrdn
Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer
Low
Report
Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer